只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-10 2026-07-10 | TSHA Taysha Gene Therapies, Inc. | Nagendran Sukumar Director,Officer · President and Head of R&D | 卖出（S） | 200,000 | US$6.24 | US$124.8万 | 936,410 | SEC |
| 2026-07-01 2026-07-06 | RARE Ultragenyx Pharmaceutical Inc. | Horn Howard Officer · Chief Financial Officer | 卖出（S） | 4,698 | US$33.13 | US$155,644.74 | 100,991 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 1,380 | US$291.69 | US$402,532.20 | 101,845 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 2,368 | US$292.47 | US$692,568.96 | 99,477 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 6,732 | US$293.48 | US$197.57万 | 92,745 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 4,739 | US$294.37 | US$139.5万 | 88,006 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 4,881 | US$295.42 | US$144.19万 | 83,125 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 900 | US$296.18 | US$266,562.00 | 82,225 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 15,482 | US$297.37 | US$460.39万 | 66,743 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 200 | US$298.30 | US$59,660.00 | 66,543 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 200 | US$300.04 | US$60,008.00 | 66,343 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 123 | US$284.80 | US$35,030.40 | 104,502 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 200 | US$289.21 | US$57,842.00 | 103,225 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 577 | US$286.06 | US$165,056.62 | 103,925 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 400 | US$287.35 | US$114,940.00 | 103,525 | SEC |
| 2026-06-18 2026-06-22 | MOD MODINE MANUFACTURING CO | Agen Brian Jon Officer · VP, CHRO | 卖出（S） | 100 | US$288.08 | US$28,808.00 | 103,425 | SEC |
| 2026-06-15 2026-06-15 | RARE Ultragenyx Pharmaceutical Inc. | Parschauer Karah Herdman Officer · EVP and Chief Legal Officer | 卖出（S） | 1,899 | US$24.62 | US$46,753.38 | 94,462 | SEC |
| 2026-06-15 2026-06-15 | RARE Ultragenyx Pharmaceutical Inc. | Sanders Corazon (Corsee) D. Director | 卖出（S） | 2,000 | US$25.05 | US$50,100.00 | 21,095 | SEC |
| 2026-06-05 2026-06-10 | MGX Metagenomi Therapeutics, Inc. | Wein Matthew Officer · See Remarks | 卖出（S） | 558 | US$1.30 | US$725.40 | 126,491 | SEC |
| 2026-06-05 2026-06-10 | MGX Metagenomi Therapeutics, Inc. | Irish Jian Director,Officer · See Remarks | 卖出（S） | 3,737 | US$1.30 | US$4,858.10 | 377,533 | SEC |
| 2026-06-05 2026-06-10 | MGX Metagenomi Therapeutics, Inc. | Wapnick Pamela Officer · Chief Financial Officer | 卖出（S） | 2,884 | US$1.30 | US$3,749.20 | 208,491 | SEC |
| 2026-06-01 2026-06-01 | RARE Ultragenyx Pharmaceutical Inc. | Horn Howard Officer · Chief Financial Officer | 卖出（S） | 4,653 | US$23.77 | US$110,601.81 | 105,689 | SEC |
| 2026-05-18 2026-05-18 | RARE Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ Director | 卖出（S） | 5,740 | US$25.12 | US$144,188.80 | 27,951 | SEC |
| 2026-05-05 2026-05-06 | RARE Ultragenyx Pharmaceutical Inc. | Crombez Eric Officer · EVP and Chief Medical Officer | 卖出（S） | 344 | US$24.96 | US$8,586.24 | 111,189 | SEC |
| 2026-05-01 2026-05-04 | RARE Ultragenyx Pharmaceutical Inc. | Horn Howard Officer · Chief Financial Officer | 卖出（S） | 4,683 | US$24.90 | US$116,606.70 | 110,342 | SEC |
| 2026-04-30 2026-05-04 | RIVN Rivian Automotive, Inc. / DE | Volkswagen US-Holding, Inc. TenPercentOwner | 买入（P） | 62,889,522 | US$15.90 | US$10亿 | 209,769,645 | SEC |
| 2026-04-30 2026-05-04 | RIVN Rivian Automotive, Inc. / DE | VOLKSWAGEN AG TenPercentOwner | 买入（P） | 62,889,522 | US$15.90 | US$10亿 | 209,769,645 | SEC |
| 2026-04-10 2026-04-13 | TSHA Taysha Gene Therapies, Inc. | Nagendran Sukumar Director,Officer · President and Head of R&D | 卖出（S） | 200,000 | US$4.46 | US$892,000.00 | 1,136,410 | SEC |
| 2026-04-01 2026-04-02 | RARE Ultragenyx Pharmaceutical Inc. | Horn Howard Officer · Chief Financial Officer | 卖出（S） | 4,683 | US$20.97 | US$98,202.51 | 80,351 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| AGEN | 327,293.1938 | 7,023 | 745,131.3893 | 43.92% | B, Q, N |